BCM
GRTS

Bayesian Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bayesian Capital Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,403
Closed -$22.2K – 1072
2023
Q2 		$22.2K Sell
11,403
-12,897
-53% -$30.2K ﹤0.01% 744
2023
Q1 		$67.6K Buy
+24,300
New +$69.4K 0.01% 704
2022
Q2 		– Sell
-22,370
Closed -$92K – 1151
2022
Q1 		$92K Buy
+22,370
New +$119K 0.01% 702

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bayesian Capital Management's GRTS Position: Q3 2023 in Review

Bayesian Capital Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2023, closing a stake of 11,403 shares — an estimated $22.2K sold.

Bayesian Capital Management first reported a position in GRTS in Q1 2022 and held it in 3 quarters. The position peaked at $92K in Q1 2022. 89 funds tracked by Wall St. Rank hold GRTS as of Q3 2023.

  • Bayesian Capital Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 11,403 Gritstone bio, Inc. Common Stock shares in Q3 2023, an estimated $22.2K.
  • Bayesian Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Bayesian Capital Management's Gritstone bio, Inc. Common Stock position peaked at $92K in Q1 2022.
  • 89 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2023.

Based on Bayesian Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.